{"id":860115,"date":"2025-06-12T10:09:15","date_gmt":"2025-06-12T14:09:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/"},"modified":"2025-06-12T10:09:15","modified_gmt":"2025-06-12T14:09:15","slug":"attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/","title":{"rendered":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!"},"content":{"rendered":"
\n

PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Manhattan Associates, Inc. (NASDAQ: MANH):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating whether certain officers and directors of Manhattan Associates, Inc. (NASDAQ: MANH) breached their fiduciary duties owed to the company.<\/p>\n

If you have held Manhattan Associates, Inc. (NASDAQ: MANH) shares since prior to October 22, 2024, and would like to learn more about the investigation and your rights, please visit https:\/\/grabarlaw.com\/the-latest\/manh-shareholder-investigation\/<\/a>, contact Joshua Grabar at jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085.<\/p>\n

\n Why?<\/strong> A recently filed securities fraud class action complaint alleges that Manhattan Associates, Inc. (NASDAQ: MANH), through certain of its officers, provided investors with material information concerning Manhattan Associates\u2019 expected revenue for the fiscal year 2025. These statements included, among other things, confidence in the Company\u2019s ability to forecast guidance despite macroeconomic fluctuations, the growth potential of their professional services offerings, and the ability for their cloud revenue to drive revenue for its professional services.<\/p>\n

The underlying complaint alleges that Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of Manhattan Associates\u2019 forecasting ability for its professional services; notably, the Company was either not truly equipped to deliver \u201cresponsible targets\u201d for growth or, otherwise, Manhattan Associates\u2019 services were not equipped to achieve such targets. Finally, the Complaint alleges that such statements absent these material facts caused Plaintiff and other shareholders to purchase Manhattan Associates\u2019 securities at artificially inflated prices.<\/p>\n

\n What You Can Do Now:<\/strong> Current Manhattan Associates shareholders who have held Manhattan Associates shares since prior to October 22, 2024, are encourage to visit https:\/\/grabarlaw.com\/the-latest\/manh-shareholder-investigation\/<\/a>, contact Joshua H. Grabar at jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085. You can <\/strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong><\/p>\n

$MANH #ManhattanAssociates<\/p>\n

\n
\n Mercury Systems, Inc. (NASDAQ: MRCY) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of Mercury Systems, Inc. (NASDAQ: MRCY) shareholders as securities fraud class action complaint partially survives motion to dismiss<\/strong>.<\/p>\n

\n Current Mercury Systems shareholders who have held shares since prior to <\/strong>
\n February 3, 2021<\/strong>
\n , <\/strong>
\n can <\/strong>
\n seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever.<\/strong>
\n To learn more or join<\/strong>
\n click here:<\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/mercury-systems-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>
\n contact Joshua H. Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call us at 267-507-6085.<\/strong>\n <\/p>\n

\n WHY<\/strong>
\n :<\/strong>
\n A recently filed securities fraud class action complaint has now partially survived defendants\u2019 attempts to dismiss that complaint.<\/strong> The underlying complaint alleges that Mercury Systems, through certain of its officers and directors, used acquisitions and improper revenue recognition practices to mask its inability to grow organically. The complaint further alleges that Defendants repeatedly misled investors to believe that their growth was organic by misrepresenting several elements of Mercury\u2019s business, including by hiding that Mercury had switched from \u201cpoint-in-time\u201d to \u201clong-term contracts\u201d in order to improperly boost reported revenues and that several of Mercury\u2019s projects were in significant distress, including projects related to Mercury\u2019s acquisition of Physical Optics Corporation. Finally, the Complaint alleges Mercury also lied to investors about its strategic growth initiative, 1MPACT, which was designed to improve profit margins but unbeknownst to investors was used to disguise regular expenses as restructuring costs, enabling Mercury to claim that recurring expenses were one-time costs.<\/p>\n

\n On February 20, 2025, a Federal Court determined that certain key allegations in the plaintiff\u2019s underlying securities fraud class action complaint were adequately pleaded to survive defendants attempts to dismiss the complaint. <\/strong>\n <\/p>\n

\n WHAT YOU CAN DO NOW: <\/strong>
\n If you have held Mercury Systems shares since prior to <\/strong>
\n February 3, 2021<\/strong>, and<\/strong> would like to learn more about this matter, you are encouraged to visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/mercury-systems-shareholder-investigation\/<\/strong><\/a>, contact Joshua H. Grabar at jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085. $MRCY #MercurySystems<\/p>\n

\n
\n Methode Electronics, Inc. (NYSE: MEI):<\/u>
\n <\/strong>\n <\/p>\n

\n Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022<\/strong>, can <\/strong>seek corporate reforms, the return of funds back to the company,<\/strong>and a court approved incentive award – all<\/strong>at no cost to them whatsoever<\/strong>. To learn more visit:<\/strong>https:\/\/grabarlaw.com\/the-latest\/methode-shareholder-investigation\/<\/strong><\/a>, contact Joshua Grabar at <\/strong>jgrabar@grabarlaw.com<\/strong><\/a>, or call 267-507-6085<\/strong>.<\/p>\n

\n Why: <\/strong>A recently filed underlying securities fraud class action complaint alleges that Methode Electronics, via certain of its officers and directors, made false and\/or misleading statements and\/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics\u2019 transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics\u2019 attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle (\u201cEV\u201d) space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics\u2019 strategic plans; (iii) Methode Electronics\u2019 manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis.<\/p>\n

\n What You Can Do Now: <\/strong>
\n Current Methode Electronics shareholders who have held Methode Electronics stock since prior to June 23, 2022<\/strong>, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever.<\/p>\n

If you would like to learn more about this matter, you are encouraged to visit https:\/\/grabarlaw.com\/the-latest\/methode-shareholder-investigation\/<\/a>, contact Joshua Grabar at\u00a0jgrabar@grabarlaw.com<\/a>, or call 267-507-6085. #Methode #MethodeElectronics $MEI<\/p>\n

\n
\n Treace Medical Concepts, Inc. (NASDAQ: TMCI)<\/u>
\n <\/strong>\n <\/p>\n

\n If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to <\/strong>
\n May 8, 2023, you can<\/strong>
\n seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you<\/strong>. Visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/treace-shareholder-investigation\/<\/a>, or <\/strong>contact Joshua H. Grabar at\u00a0<\/strong>jgrabar@grabarlaw.com<\/a>or call 267-507-6085 <\/strong>to learn more.<\/strong><\/p>\n

Why?<\/strong> A recently filed securities class action complaint alleges that, Treace Medical Concepts, Inc. (NASDAQ: TMCI), via certain of its officers, made materially false and\/or misleading statements and failed to disclose adverse facts about the Company\u2019s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical\u2019s revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n

\n What You Can Do Now: <\/strong>
\n Current Treace shareholders who have held Treace shares since prior to May 8, 2023,<\/strong>
\n can <\/strong>
\n seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. <\/strong>
\n If you would like to learn more about this matter, you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/treace-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact us at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , or call 267-507-6085.<\/strong> #Treace $TMCI<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) — Manhattan Associates, Inc. (NASDAQ: MANH): Grabar Law Office is investigating whether certain officers and directors of Manhattan Associates, Inc. (NASDAQ: MANH) breached their fiduciary duties owed to the company. If you have held Manhattan Associates, Inc. (NASDAQ: MANH) shares since prior to October 22, 2024, and would like to learn more about the investigation and your rights, please visit https:\/\/grabarlaw.com\/the-latest\/manh-shareholder-investigation\/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. Why? A recently filed securities fraud class action complaint alleges that Manhattan Associates, Inc. (NASDAQ: MANH), through certain of its officers, provided investors with material information concerning Manhattan Associates\u2019 expected revenue for the fiscal year 2025. These statements included, among other things, confidence … <\/p>\n

Continue reading “Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-860115","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAttention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) — Manhattan Associates, Inc. (NASDAQ: MANH): Grabar Law Office is investigating whether certain officers and directors of Manhattan Associates, Inc. (NASDAQ: MANH) breached their fiduciary duties owed to the company. If you have held Manhattan Associates, Inc. (NASDAQ: MANH) shares since prior to October 22, 2024, and would like to learn more about the investigation and your rights, please visit https:\/\/grabarlaw.com\/the-latest\/manh-shareholder-investigation\/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. Why? A recently filed securities fraud class action complaint alleges that Manhattan Associates, Inc. (NASDAQ: MANH), through certain of its officers, provided investors with material information concerning Manhattan Associates\u2019 expected revenue for the fiscal year 2025. These statements included, among other things, confidence … Continue reading "Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-12T14:09:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!\",\"datePublished\":\"2025-06-12T14:09:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/\"},\"wordCount\":1375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/\",\"name\":\"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=\",\"datePublished\":\"2025-06-12T14:09:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/","og_locale":"en_US","og_type":"article","og_title":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk","og_description":"PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) — Manhattan Associates, Inc. (NASDAQ: MANH): Grabar Law Office is investigating whether certain officers and directors of Manhattan Associates, Inc. (NASDAQ: MANH) breached their fiduciary duties owed to the company. If you have held Manhattan Associates, Inc. (NASDAQ: MANH) shares since prior to October 22, 2024, and would like to learn more about the investigation and your rights, please visit https:\/\/grabarlaw.com\/the-latest\/manh-shareholder-investigation\/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. Why? A recently filed securities fraud class action complaint alleges that Manhattan Associates, Inc. (NASDAQ: MANH), through certain of its officers, provided investors with material information concerning Manhattan Associates\u2019 expected revenue for the fiscal year 2025. These statements included, among other things, confidence … Continue reading \"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-12T14:09:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!","datePublished":"2025-06-12T14:09:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/"},"wordCount":1375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/","name":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf! - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=","datePublished":"2025-06-12T14:09:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2Nzg1NyM2OTg4NjU5IzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-investors-of-manhattan-associates-inc-nasdaq-manh-mercury-systems-inc-nasdaq-mrcy-methode-electronics-inc-nyse-mei-and-treace-medical-concepts-inc-nasdaq-tmci\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) \u2013 Grabar Law Office is Investigating Claims on Your Behalf!"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/860115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=860115"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/860115\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=860115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=860115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=860115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}